Best in Biotech 18 Mar 2025 Cancer vaccines: 11 biotechs to keep an eye out for …Situated in the brimming biotech hub in Cambridge, Massachusetts, Elicio Therapeutics specializes in immunotherapeutic research in the field of cancer and infectious diseases. And its amphiphile technology (AMP) platform is… March 18, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 26 Mar 2025 A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations …implicated in numerous diseases, particularly cancer. This is where kinase inhibitors come into play. Kinases have become one of the most extensively targeted enzymes in drug development. While traditional chemotherapies… March 26, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 12 Jan 2024 Could natural killer cells transform Alzheimer’s treatment? …various diseases, whether it be autoimmune diseases or cancer susceptibility, is there a therapy for that?” Song said. So, the company set about developing a natural killer cell therapy to… January 12, 2024 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Jan 2023 BioNTech partnering with UK Government on personalized mRNA cancer immunotherapies …diseases affecting collectively hundreds of millions of people worldwide. If successful, this collaboration has the potential to improve outcomes for patients and provide early access to our suite of cancer… January 6, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 13 Mar 2017 This Dutch Company is Upgrading ADCs for Immunotherapy …Xenikos, in 2009 to further refine T-Guard as a treatment for acute graft-versus-host disease (GVHD) and other orphan diseases. We talked to him about his technology and company outlook. What… March 13, 2017 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 23 Jul 2018 Sangamo Acquires French Biotech to Develop CAR-T Therapies for Autoimmune Disease …focussed biotechs are combating cancer, TxCell is going one step further by developing CAR-T therapies for autoimmune diseases using a different type of CAR-T cell. Usually, CAR-T therapies use killer… July 23, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 21 Nov 2016 “We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease” …Regarding R&D, our territory is expanding from rare diseases to immune modulation using our mesenchymal stem cells (MSC’s). Our MSC’s are called HepaStem, which were originally used for UCD for… November 21, 2016 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
In Depth 29 Aug 2025 Can genetically modified crops help us adapt to climate change? …diseases, or herbicides, improve their nutritional value, or enhance their tolerance to harsh environmental conditions. Humans have been using traditional modification methods like selective breeding and crossbreeding to create plants… August 29, 2025 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2023 Ubiquigent and University of Glasgow to collaborate on drug discovery …University of Glasgow (UoG) to undertake a research project on USP30, a DUB implicated in neruodegenerative, renal, and cardiovascular diseases. Overseen by structural biology experts Helen Walden, UoG, and Mehmet… January 24, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 21 Apr 2023 RetinAI and Boehringer Ingelheim to use AI to develop treatment for geographic atrophy …patient outcomes in geographic atrophy (GA) by combining RetinAI’s Discovery platform and AI tools with Boehringer Ingelheim’s research in retinal diseases. GA is a progressive, advanced form of age-related macular… April 21, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 31 Aug 2022 How CDMOs keep pace with trends in advanced therapies …for protein-based therapeutics. The intracellular mode of action is expected to allow the treatment of diseases that so far could not be tackled, such as genetic diseases where patients lack… August 31, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2016 TxCell lines up another duck in its CAR-Treg campaign Novartis veteran Li Zhou has joined TxCell as the VP of cell engineering to oversee CAR-Treg programs for autoimmune and inflammation diseases. The French Treg maverick, TxCell, has hoovered up… October 17, 2016 - 2 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email